Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>Events>This Event
  Events - September 2012


Trends in Nanotechnology 2012

10 Sep 2012 - 14 Sep 2012 - Madrid, Spain



Bookmark and Share


This high-level scientific meeting aims to present a broad range of current research in Nanoscience and Nanotechnology as well as related policies (European Commission, etc.) or other kind of initiatives (nanoGUNE, FinNano, GDR-I, etc.). TNT events have demonstrated that they are particularly effective in transmitting information and establishing contacts among workers in this field.

The TNT 2012 structure will keep the fundamental features of the previous editions, providing a unique opportunity for broad interaction.

Currently, 20 keynote speakers from all over the world are confirmed covering different fields of Nanotechnology.

TNT 2012 specific Sessions, among others:
   "Atoms and molecular computing" in collaboration with AtMol EU project
   "High spatial resolution spectroscopies under SPM probe" in collaboration with CNRS-CINaM (France)
   "Nanobiotechnology" in collaboration with IBEC-UB (Spain)
   "Modeling at the nanoscale" in collaboration with nanoGUNE (Spain)

An exhibition will be set where around 15 exhibitors are expected to showcase their products, services and expertise.

The call for abstracts is now open and the deadline is the 4th of June 2012. The early bird registration fee is the 20th of June 2012.

TNT conference provides an ideal venue for industrial, academic and governmental organizations to share common objectives and drive the commercialisation of nanotechnology discoveries. Research Institutes and Universities, technology and research centres and extensive business and industrial activities give Madrid, and its surroundings, its singular potential for commercial growth and development.



Further information
Scientific News
The Rise of 3D Cell Culture and in vitro Model Systems for Drug Discovery and Toxicology
An overview of the current technology and the challenges and benefits over 2D cell culture models plus some of the latest advances relating to human health research.
Scientists Find Evidence That Cancer Can Arise Changes
Researchers at Rockefeller University have found a mutation that affects the proteins that package DNA without changing the DNA itself can cause a rare form of cancer.
Developing a More Precise Seasonal Flu Vaccine
During the 2014-15 flu season, the poor match between the virus used to make the world’s vaccine stocks and the circulating seasonal virus yielded a vaccine that was less than 20 percent effective.
A Peachy Defense System for Seeds
ETH chemists are developing a new coating method to protect seeds from being eaten by insects. In doing so, they have drawn inspiration from the humble peach and a few of its peers.
Fighting Cancer with Borrowed Immunity
A new step in cancer immunotherapy: researchers from the Netherlands Cancer Institute and University of Oslo/Oslo University Hospital show that even if one's own immune cells cannot recognize and fight their tumors, someone else's immune cells might.
Modified Microalgae Converts Sunlight into Valuable Medicine
A special type of microalgae can soon produce valuable chemicals such as cancer treatment drugs and much more just by harnessing energy from the sun.
Breakthrough Approach to Breast Cancer Treatment
Scripps scientists have designed a drug candidate that decreases growth of breast cancer cells.
Loss Of Y Chromosome Increases Risk Of Alzheimer’s
Men with blood cells that do not carry the Y chromosome are at greater risk of being diagnosed with Alzheimer’s disease. This is in addition to an increased risk of death from other causes, including many cancers. These new findings by researchers at Uppsala University could lead to a simple test to identify those at risk of developing Alzheimer’s disease.
Making Virus Sensors Cheap and Simple
Researchers at The University of Texas at Austin demonstrated the ability to detect single viruses in a solution containing murine cytomegalovirus (MCMV).
A Guide to CRISPR Gene Activation
A comparison of synthetic gene-activating Cas9 proteins can help guide research and development of therapeutic approaches.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,500+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!